Pfizer, BioNTech to ask for authorization of emergency use of COVID-19 vaccine
German company, BioNTech, and its partner, Pfizer, will ask the U.S. on Friday to allow emergency use of their COVID-19 vaccine.
German company, BioNTech, and its partner, Pfizer, will ask the U.S. on Friday to allow emergency use of their COVID-19 vaccine.
State epidemiologist Dr. Linda Bell provided a brief update about a COVID-19 vaccine this morning.
The chief leading the Oxford vaccine trials is “optimistic” it could be ready “before Christmas.”
The government is planning to pay for any future coronavirus vaccine for all Americans. The Centers for Medicare and Medicaid Services says it will pay for any vaccine authorized or approved by the Food and Drug Administration.
Pfizer says it expects to apply for public use of its coronavirus vaccine candidate in the third week of November, if everything goes according to plan. The emergency use authorization will be requested through the U.S. Food and Drug Administration.
Drugmaker Pfizer is planning to start testing its experimental coronavirus vaccine on children as young as 12. The researcher leading the drug trial says parents have already expressed interest in enrolling their kids.
Image: CNN (CNN)— The US Food and Drug Administration made clear Tuesday it will want to see two months of follow-up data after volunteers get their second dose of vaccine as part of clinical trials testing potential coronavirus vaccines. That would make it difficult, if not impossible, for any vaccine maker to apply for emergency use authorization by Election Day,…